Corrigendum: IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation. Biomol Biomed [Internet]. 2023 May 1 [cited 2024 May 4];23(3):545. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/8739